Iopamidol

DRUG13 trials

Sponsors

Bracco Diagnostics, Inc, GE Healthcare, Azienda Policlinico Umberto I, Duke University, IRCCS Policlinico S. Donato

Conditions

Breast CancerCT of the Abdomen and Pelvis With Contrast MaterialContrast Agent With Lean Body WeightContrast Media Adverse ReactionCoronary Artery StenosisDrug SafetyDuodenal NeoplasmER Positive Breast Cancer

Phase 1

Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer

TerminatedNCT04504331

Jennifer Lee Caswell-JinBreast Cancer, ER Positive Breast Cancer, HER2-negative Breast Cancer +1

Start: 2020-10-13End: 2021-10-22Updated: 2026-02-12

Phase 2

Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy

RecruitingNCT06411795

Masonic Cancer Center, University of MinnesotaDuodenal Neoplasm, Pancreatic Neoplasm

Start: 2023-11-10End: 2028-01-01Target: 78Updated: 2026-02-03

Phase 4

Isovue in Peripheral Digital Subtraction Angiography (DSA)

CompletedNCT01075217

Bracco Diagnostics, IncPeripheral Arterial Occlusive Disease

Start: 2010-04-30End: 2011-12-31Updated: 2013-05-30

Kidney Damage in Patients With Moderate Fall in eGFR

CompletedNCT01136876

Bracco Diagnostics, IncCoronary Artery Stenosis

Start: 2010-11-30End: 2012-11-30Updated: 2020-11-04

Iodixanol Versus Iopamidol in Patients Undergoing Contrast-Enhanced Computed Tomographic Imaging of Abdomen/Pelvis

CompletedNCT01376089

GE HealthcarePatient Comfort and Safety

Start: 2011-05-31End: 2012-02-29Updated: 2013-12-19

Comparing Patient Comfort and Safety Between Iodixanol and Iopamidol in Patients Undergoing Peripheral Arteriography

CompletedNCT01475097

GE HealthcareDrug Safety

Start: 2011-10-31End: 2013-02-28Updated: 2014-06-11

Low-dose Laxative Improves Performance and Feasibility of Computed Tomography Colonography (CTC)

CompletedNCT02040285

Azienda Policlinico Umberto IGastrointestinal Complication

Start: 2012-02-29End: 2012-07-31Updated: 2014-01-20

Optimization of Contrast Agent Dose in CT With Lean Body Weight

CompletedNCT03384979

IRCCS Policlinico S. DonatoContrast Agent With Lean Body Weight

Start: 2017-12-18End: 2019-02-25Updated: 2019-05-06

Adenosine Contrast CorrELations in Evaluating RevAscularizaTION

CompletedNCT03557385

Duke UniversityPercutaneous Coronary Intervention

Start: 2019-01-17End: 2023-04-04Updated: 2024-07-05

Unknown Phase

Customized Contrast Media Dose Clinical Trial

TerminatedNCT02433665

Duke UniversityCT of the Abdomen and Pelvis With Contrast Material

Start: 2015-08-31End: 2016-10-06Updated: 2020-06-16

Study With Oral Isovue in Abdominopelvic CT

CompletedNCT04453059

Bracco Diagnostics, IncPatients Requiring Abdominopelvic CT With Oral Administration of Contrast

Start: 2021-07-01End: 2022-07-01Updated: 2023-02-08

Advanced MRI Scan Before and After Radiation Therapy for the Detection of Intracranial Metastasis

CompletedNCT04870645

M.D. Anderson Cancer CenterMalignant Solid Neoplasm

Start: 2021-03-30End: 2023-08-29Updated: 2024-11-06

Effects of Contrast Media Temperature on Image Quality and Clinical Adverse Events in Coronary CTA

Chongqing Emergency Medical CenterContrast Media Adverse Reaction

Start: 2022-02-01End: 2023-02-28Target: 500Updated: 2022-08-05

Related Papers

Effects of extrinsically warmed contrast media on image quality and clinical adverse events in patients undergoing coronary computed tomography angiography: a randomized controlled trial.

2025-12-31

Adenosine Contrast Correlations in Evaluating Revascularization: The (ACCELERATION) Study

Circulation Cardiovascular Interventions2025-04-24

Lean body weight versus total body weight to calculate the iodinated contrast media volume in abdominal CT: a randomised controlled trial.

2020-12-0911 citations